Table 4.

Analysis of QLQ-BR23 Scores by Treatment Method

Scale	Group	N	Mean	SD	Median	p *
Body image	BCT	50	74.5	24.99	83.33	0.001
	MTX	50	57.39	24.25	62.5	MTX<
	MTX+R	50	69.33	22.24	66.67	Other
Sexual functioning	BCT	50	22.67	23.27	25	<0.001
	MTX	50	14.67	18.33	0	MTX+R
	MTX+R	50	33.67	24.16	33.33	>other
Sexual enjoyment	BCT	48	36.11	31.39	33.33	<0.001
	MTX	30	31.11	31.48	33.33	MTX+R
	MTX+R	34	65.69	34.31	66.67	>other
Future perspective	BCT	49	23.13	29.03	0	0.071
	MTX	50	29.33	29.07	33.33
	MTX+R	50	36.67	29.55	33.33
Treatment side effects	BCT	50	27.21	20.39	21.43	0.139
	MTX	50	27.75	18.2	28.57
	MTX+R	50	20.91	15.1	19.05
Breast problems	BCT	50	24.67	22.08	25	0.161
	MTX	50	21.56	23.61	8.33
	MTX+R	49	17.01	21.71	8.33
Arm problems	BCT	50	18.67	17.88	11.11	0.319
	MTX	50	24.89	21.48	22.22
	MTX+R	49	21.77	19.77	22.22
Hair loss	BCT	20	45	40.86	33.33	0.639
	MTX	23	55.07	35.69	33.33
	MTX+R	17	52.94	35.47	66.67

Note: *Kruskal–Wallis test + post hoc analysis (Dunn test).